The customer's calibration, qc, sample pre-analytical details, and system alarm trace were requested but not provided.The patient's sample was provided for an investigation.The investigation tested the patient's sample on a cobas 8000 e 801 module and the ft4 result was 1.80 ng/dl and the tsh result was 0.083 uiu/ml.The investigation reproduced the customer's ft4 and tsh result.The observed differences in ft4 values generated with the roche assay and the abbott assay are most likely caused by differences in the overall setups of the assays, the antibodies used, differences in reference materials, and the differences in the standardization methodology used.For the assay tsh, an interferent against a component of the reagent was confirmed, ruthenium label.This interference is covered in product labeling: per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
|